HMP Global February 28, 2025
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored research, barriers posed by inclusion and exclusion criteria, and the role of clinical pathways and payers in facilitating trial access.
John Hennessy, MBA: Hi, I’m John Hennessey. I’m a principal with Valuate Health Consultancy, and I’m with Mike Kolodziej, my partner in our series Breaking Down Health Care. Today we’re going to talk about a topic that’s important to cancer patients and to cancer professionals across the board, and that’s clinical trials. Clinical trials are hopefully a part of what we do in oncology. Mike, you’ve been...
Today's Sponsors
Today's Sponsor